These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation. Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570 [TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
5. Early stopping rules in oncology: considerations for clinicians. Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153 [TBL] [Abstract][Full Text] [Related]
6. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data. Shimura M; Gosho M; Hirakawa A Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076 [TBL] [Abstract][Full Text] [Related]
7. Interpretation of Clinical Trials That Stopped Early. Viele K; McGlothlin A; Broglio K JAMA; 2016 Apr; 315(15):1646-7. PubMed ID: 27092832 [No Abstract] [Full Text] [Related]
9. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit. Royston P; Barthel FM; Parmar MK; Choodari-Oskooei B; Isham V Trials; 2011 Mar; 12():81. PubMed ID: 21418571 [TBL] [Abstract][Full Text] [Related]
10. Group Sequential Design for Randomized Phase III Trials under the Weibull Model. Wu J; Xiong X J Biopharm Stat; 2015; 25(6):1190-205. PubMed ID: 25322440 [TBL] [Abstract][Full Text] [Related]
11. Information time scales for interim analyses of randomized clinical trials. Freidlin B; Othus M; Korn EL Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947 [TBL] [Abstract][Full Text] [Related]
12. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Alfaleh K; Bassler D Cochrane Database Syst Rev; 2008 Jan; (1):CD005496. PubMed ID: 18254081 [TBL] [Abstract][Full Text] [Related]
13. Probiotics for prevention of necrotizing enterocolitis in preterm infants. AlFaleh K; Anabrees J Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307 [TBL] [Abstract][Full Text] [Related]
14. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance. Shen W; Ning J; Yuan Y Stat Med; 2015 Jun; 34(13):2104-15. PubMed ID: 25756852 [TBL] [Abstract][Full Text] [Related]
15. Early Termination of Randomized Clinical Trials in Orthopaedics. Piuzzi N; Chughtai M; Khlopas A; Gwam CU; Muschler G; Spindler KP; Mont MA Surg Technol Int; 2017 Feb; 30():290-294. PubMed ID: 28182822 [TBL] [Abstract][Full Text] [Related]
16. Robust meta-analytic-predictive priors in clinical trials with historical control information. Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546 [TBL] [Abstract][Full Text] [Related]
17. Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial. Lesaffre E; Edelman MJ; Hanna NH; Park K; Thatcher N; Willemsen S; Gaschler-Markefski B; Kaiser R; Manegold C Ann Oncol; 2017 Jul; 28(7):1419-1426. PubMed ID: 28184431 [TBL] [Abstract][Full Text] [Related]
18. Influence of adaptive analysis on unnecessary patient recruitment: reanalysis of the RATPAC trial. Sutton L; Julious SA; Goodacre SW Ann Emerg Med; 2012 Oct; 60(4):442-8.e1. PubMed ID: 22632776 [TBL] [Abstract][Full Text] [Related]
19. Data monitoring committees, interim analysis and early termination in paediatric trials. Fernandes RM; van der Lee JH; Offringa M Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998 [TBL] [Abstract][Full Text] [Related]
20. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial. Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]